Wellnest

JUNE 19, 2023

With the continued evolution of AI, it is now being introduced in cardiac healthcare, promising opportunities for innovation and advancements in cardiovascular medicine. The deep learning algorithm helps segment the left ventricle predicting cardiomyopathy and ejection fraction. For instance: 1.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

Dr. S. Venkatesan MD

FEBRUARY 20, 2024

In myocardial pathology, the genesis and sustainability of ventricular arrhythmia are intricately related to the degree of LV dysfunction of any cause. Still, Mirowski”s electrical kid survived the test of time and evolved with great technological innovations from companies like Medtronic, Guidant, Abbot etc. Circulation.

Defibrillator 52

Defibrillator Heart Failure Sudden Cardiac Death Cardiomyopathy 52

Cardiometabolic Health Congress

JANUARY 2, 2025

November 2024 Approvals Acoramidis Approval Date: November 22, 2024 Indication: Approved for adults with transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and severe cardiac condition. Heart rate decrease criteria: >20% decrease, HR <100 bpm, or arrhythmia cessation. Placebo: 0%-11%. Adverse events : Landiolol: 9.9%.

Coronary Artery Disease 52

Coronary Artery Disease Innovation Stents Stent 52